<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02119325</url>
  </required_header>
  <id_info>
    <org_study_id>202180</org_study_id>
    <secondary_id>RH01899</secondary_id>
    <nct_id>NCT02119325</nct_id>
  </id_info>
  <brief_title>The Effect of a Nutritional Supplement on Post Prandial Glucose and Lipids in an Adult Population</brief_title>
  <official_title>The Effect of a Nutritional Supplement on Post Prandial Glucose and Lipids in an Adult Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to evaluate the effect of a fibre rich health food drink on
      the post prandial glucose and triglyceride peak in healthy overweight adults with impaired
      fasting glucose (IFG). The study is randomised, stratified, double blind, two treatments, two
      period cross over study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cmax for Glucose in IFG Status Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for glucose in healthy overweight adults with impaired fasting glucose (IFG)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cmax for Triglyceride in IFG Status Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for triglyceride in healthy overweight adults with IFG</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cmax for Glucose in Overweight Healthy Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for glucose in healthy overweight adults</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC for Glucose in Overweight Healthy Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on area under the curve (AUC) for glucose in healthy overweight adults</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tmax for Glucose in Overweight Healthy Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on the time when maximum post prandial concentration is reached (Tmax) of blood glucose in healthy overweight adults</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cmax for Triglyceride in Overweight Healthy Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for triglyceride in healthy overweight adults</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC for Triglycerides in Overweight Healthy Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on area under the curve (AUC) for triglycerides in healthy overweight adults</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tmax for Triglycerides in Overweight Healthy Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on Tmax of triglycerides in healthy overweight adults</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cmax for RLP Cholesterol in IFG Status Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on post prandial Remnant Lipoprotein Cholesterol (RLP Cholesterol) peak (Cmax) in healthy overweight adults with IFG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC for RLP Cholesterol in IFG Status Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on AUC for RLP Cholesterol in healthy overweight adults with IFG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tmax for RLP Cholesterol in IFG Status Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on Tmax for RLP Cholesterol in healthy overweight adults with IFG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cmax for RLP Cholesterol in Overweight Healthy Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on post prandial RLP Cholesterol peak (Cmax) in healthy overweight adults</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC for RLP Cholesterol in Overweight Healthy Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on AUC for RLP Cholesterol in healthy overweight adults</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tmax for RLP Cholesterol in Overweight Healthy Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on Tmax of RLP Cholesterol in healthy overweight adults</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cmax for Insulin in IFG Status Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for insulin in healthy overweight adults with IFG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC for Insulin in IFG Status Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on AUC for insulin in healthy overweight adults with IFG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tmax for Insulin in IFG Status Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on Tmax for insulin in healthy overweight adults with IFG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cmax for Insulin in Overweight Healthy Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for insulin in healthy overweight adults</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC for Insulin in Overweight Healthy Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on AUC for insulin in healthy overweight adults</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tmax for Insulin in Overweight Healthy Participants</measure>
    <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
    <description>To evaluate the effect of fibre rich health food drink on Tmax for insulin in healthy overweight adults</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Impaired Fasting Glucose</condition>
  <arm_group>
    <arm_group_label>Test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>25% fibre</intervention_name>
    <description>Test is a powdered beverage with an active component of 25% of fibre (resistant maltodextrin)</description>
    <arm_group_label>Test</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>0% fibre</intervention_name>
    <description>Placebo is an energy matched powdered beverage</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy overweight male and female participants

          -  Age 18-75 years

          -  BMI â‰¥25&lt;35 Kg/m2

        Exclusion Criteria:

          -  Pregnancy/breast-feeding

          -  Allergy/Intolerance

          -  Anaemic participants: Hb &lt;10g/dL

          -  Diabetic participants: fasting blood glucose &gt;125 mg/dL

          -  Serum Aspartate Transaminase, Alkaline Phosphatase and Serum albumin level 3 times the
             upper limit of normal range

          -  Participants on other medications (lipid lowering drugs, oral hypoglycemics)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lambda Therapeutic Research Ltd</name>
      <address>
        <city>Ahmedabad</city>
        <state>Gujarat</state>
        <zip>380 061</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2014</study_first_submitted>
  <study_first_submitted_qc>April 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2014</study_first_posted>
  <results_first_submitted>June 5, 2014</results_first_submitted>
  <results_first_submitted_qc>May 11, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 15, 2015</results_first_posted>
  <last_update_submitted>May 11, 2015</last_update_submitted>
  <last_update_submitted_qc>May 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 15, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fibre</keyword>
  <keyword>overweight</keyword>
  <keyword>impaired fasting glucose</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were mainly recruited from the study site database.</recruitment_details>
      <pre_assignment_details>Of the 210 participants screened, 114 participants were not randomised. The reasons for the same were: not meeting study criteria (n=42), lost to follow-up (n=5), and other reasons (n=67).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Sequence 1</title>
          <description>Participants were adminisetered with Test followed by Placebo. Test comprised of a fibre rich health food drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin). Placebo was a 'No fibre' health food drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
        </group>
        <group group_id="P2">
          <title>Sequence 2</title>
          <description>Participants were administered with Placebo followed by Test. Test comprised of a fibre rich health food drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin). Placebo was a 'No fibre' health food drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout Period 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="48"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Period 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall Participants</title>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="96"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.9" spread="7.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Impaired fasting glucose (IFG) status</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>IFG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No IFG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cmax for Glucose in IFG Status Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for glucose in healthy overweight adults with impaired fasting glucose (IFG)</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibe (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax for Glucose in IFG Status Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for glucose in healthy overweight adults with impaired fasting glucose (IFG)</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.76" spread="24.229"/>
                    <measurement group_id="O2" value="47.40" spread="23.233"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>H0: There was no difference in the post prandial glucose peak for participants with IFG between the test and placebo.
The primary parameter was analysed using a mixed effects model with glucose as dependent variable, treatment and period as fixed effects and subject as random effect.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.0487</p_value>
            <p_value_desc>Statistical significance at the 5% level was required for both co-primary endpoints in order to progress to formal assessment of secondary endpoints.</p_value_desc>
            <method>ANOVA</method>
            <param_type>Difference in Adjusted Mean</param_type>
            <param_value>-4.64</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-9.26</ci_lower_limit>
            <ci_upper_limit>-0.03</ci_upper_limit>
            <estimate_desc>Difference is test minus placebo such that a positive difference means the test has higher Cmax</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cmax for Triglyceride in IFG Status Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for triglyceride in healthy overweight adults with IFG</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax for Triglyceride in IFG Status Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for triglyceride in healthy overweight adults with IFG</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121.07" spread="46.484"/>
                    <measurement group_id="O2" value="127.85" spread="72.565"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>H0: There was no difference in the post prandial triglyceride peak for participants with IFG between the test and placebo.
The primary parameter was analysed using a mixed effects model with triglyceride as dependent variable, treatment and period as fixed effects and subject as random effect.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.6116</p_value>
            <p_value_desc>Statistical significance at the 5% level was required for both co-primary endpoints in order to progress to formal assessment of secondary endpoints.</p_value_desc>
            <method>ANOVA</method>
            <param_type>Difference in Adjusted Mean</param_type>
            <param_value>-6.79</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-34.02</ci_lower_limit>
            <ci_upper_limit>20.44</ci_upper_limit>
            <estimate_desc>Difference is test minus placebo such that a positive difference means the test has higher Cmax</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cmax for Glucose in Overweight Healthy Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for glucose in healthy overweight adults</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax for Glucose in Overweight Healthy Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for glucose in healthy overweight adults</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.98" spread="17.687"/>
                    <measurement group_id="O2" value="43.64" spread="19.220"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AUC for Glucose in Overweight Healthy Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on area under the curve (AUC) for glucose in healthy overweight adults</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>AUC for Glucose in Overweight Healthy Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on area under the curve (AUC) for glucose in healthy overweight adults</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>mg*min/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27163.93" spread="2804.549"/>
                    <measurement group_id="O2" value="27329.59" spread="3040.290"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tmax for Glucose in Overweight Healthy Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on the time when maximum post prandial concentration is reached (Tmax) of blood glucose in healthy overweight adults</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax for Glucose in Overweight Healthy Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on the time when maximum post prandial concentration is reached (Tmax) of blood glucose in healthy overweight adults</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.74" spread="15.710"/>
                    <measurement group_id="O2" value="25.78" spread="11.972"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cmax for Triglyceride in Overweight Healthy Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for triglyceride in healthy overweight adults</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax for Triglyceride in Overweight Healthy Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for triglyceride in healthy overweight adults</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="126.20" spread="51.959"/>
                    <measurement group_id="O2" value="119.84" spread="56.151"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AUC for Triglycerides in Overweight Healthy Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on area under the curve (AUC) for triglycerides in healthy overweight adults</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>AUC for Triglycerides in Overweight Healthy Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on area under the curve (AUC) for triglycerides in healthy overweight adults</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>mg*min/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59829.76" spread="27022.972"/>
                    <measurement group_id="O2" value="60488.97" spread="29642.057"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tmax for Triglycerides in Overweight Healthy Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on Tmax of triglycerides in healthy overweight adults</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax for Triglycerides in Overweight Healthy Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on Tmax of triglycerides in healthy overweight adults</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="220.32" spread="37.115"/>
                    <measurement group_id="O2" value="218.75" spread="30.444"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cmax for RLP Cholesterol in IFG Status Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on post prandial Remnant Lipoprotein Cholesterol (RLP Cholesterol) peak (Cmax) in healthy overweight adults with IFG</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax for RLP Cholesterol in IFG Status Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on post prandial Remnant Lipoprotein Cholesterol (RLP Cholesterol) peak (Cmax) in healthy overweight adults with IFG</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>mmole/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.82" spread="0.780"/>
                    <measurement group_id="O2" value="1.30" spread="1.265"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AUC for RLP Cholesterol in IFG Status Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on AUC for RLP Cholesterol in healthy overweight adults with IFG</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>AUC for RLP Cholesterol in IFG Status Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on AUC for RLP Cholesterol in healthy overweight adults with IFG</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>mmole*min/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1765.27" spread="237.951"/>
                    <measurement group_id="O2" value="1759.01" spread="230.544"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tmax for RLP Cholesterol in IFG Status Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on Tmax for RLP Cholesterol in healthy overweight adults with IFG</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax for RLP Cholesterol in IFG Status Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on Tmax for RLP Cholesterol in healthy overweight adults with IFG</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="124.23" spread="84.068"/>
                    <measurement group_id="O2" value="125.00" spread="77.006"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cmax for RLP Cholesterol in Overweight Healthy Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on post prandial RLP Cholesterol peak (Cmax) in healthy overweight adults</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax for RLP Cholesterol in Overweight Healthy Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on post prandial RLP Cholesterol peak (Cmax) in healthy overweight adults</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>mmole/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.97" spread="1.009"/>
                    <measurement group_id="O2" value="1.33" spread="1.783"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AUC for RLP Cholesterol in Overweight Healthy Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on AUC for RLP Cholesterol in healthy overweight adults</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>AUC for RLP Cholesterol in Overweight Healthy Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on AUC for RLP Cholesterol in healthy overweight adults</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>mmole*min/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1856.49" spread="1049.372"/>
                    <measurement group_id="O2" value="1845.29" spread="904.018"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tmax for RLP Cholesterol in Overweight Healthy Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on Tmax of RLP Cholesterol in healthy overweight adults</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax for RLP Cholesterol in Overweight Healthy Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on Tmax of RLP Cholesterol in healthy overweight adults</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116.84" spread="77.088"/>
                    <measurement group_id="O2" value="130.26" spread="76.507"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cmax for Insulin in IFG Status Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for insulin in healthy overweight adults with IFG</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax for Insulin in IFG Status Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for insulin in healthy overweight adults with IFG</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>ÂµIU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="190.90" spread="75.471"/>
                    <measurement group_id="O2" value="214.90" spread="84.080"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AUC for Insulin in IFG Status Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on AUC for insulin in healthy overweight adults with IFG</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>AUC for Insulin in IFG Status Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on AUC for insulin in healthy overweight adults with IFG</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>ÂµIU*min/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24920.06" spread="10299.888"/>
                    <measurement group_id="O2" value="27066.11" spread="10666.718"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tmax for Insulin in IFG Status Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on Tmax for insulin in healthy overweight adults with IFG</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax for Insulin in IFG Status Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on Tmax for insulin in healthy overweight adults with IFG</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.46" spread="23.949"/>
                    <measurement group_id="O2" value="39.23" spread="19.115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cmax for Insulin in Overweight Healthy Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for insulin in healthy overweight adults</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Cmax for Insulin in Overweight Healthy Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on post prandial peak (Cmax) for insulin in healthy overweight adults</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>ÂµIU/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="188.84" spread="87.184"/>
                    <measurement group_id="O2" value="213.42" spread="100.641"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>AUC for Insulin in Overweight Healthy Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on AUC for insulin in healthy overweight adults</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>AUC for Insulin in Overweight Healthy Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on AUC for insulin in healthy overweight adults</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>ÂµIU*min/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21963.63" spread="10310.800"/>
                    <measurement group_id="O2" value="25089.69" spread="13421.113"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tmax for Insulin in Overweight Healthy Participants</title>
        <description>To evaluate the effect of fibre rich health food drink on Tmax for insulin in healthy overweight adults</description>
        <time_frame>Blood samples will be taken at -35, 10, 20, 30, 40, 50, 60, 75, 90, 105, 120, 150, 180, 210 &amp; 240 minutes</time_frame>
        <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
        <group_list>
          <group group_id="O1">
            <title>Test</title>
            <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
          </group>
        </group_list>
        <measure>
          <title>Tmax for Insulin in Overweight Healthy Participants</title>
          <description>To evaluate the effect of fibre rich health food drink on Tmax for insulin in healthy overweight adults</description>
          <population>The per protocol (PP) population was the primary population used for analysis. The PP population included all subjects that fulfil the study entry criteria, receive at least one of the study treatments, have enough plasma samples to estimate the efficacy parameters and are without a major protocol deviation.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="95"/>
                <count group_id="O2" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.58" spread="24.176"/>
                    <measurement group_id="O2" value="36.41" spread="21.048"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were recorded from the start of the investigational product, and until one day following last administration of the investigational product.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Test</title>
          <description>Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water. The active constituent consisted of 25% fibre (resistant maltodextrin).</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="96"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="96"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="96"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="96"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>GSK Response Center</name_or_title>
      <organization>GlaxoSmithKline</organization>
      <phone>866-435-7343</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

